| Complete Concierge Care Medical Of | |
|
5215 Loughboro Rd Nw Ste 310 Washington DC 20016-2626 | |
| (202) 244-9300 | |
| (202) 244-9301 |
| Full Name | Complete Concierge Care Medical Of |
|---|---|
| Speciality | Family Medicine |
| Location | 5215 Loughboro Rd Nw Ste 310, Washington, District Of Columbia |
| Authorized Official Name and Position | James T Williams (OWNER) |
| Authorized Official Contact | 2022449300 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Complete Concierge Care Medical Of 5215 Loughboro Rd Nw Ste 310 Washington DC 20016-2626 Ph: (202) 244-9300 | Complete Concierge Care Medical Of 5215 Loughboro Rd Nw Ste 310 Washington DC 20016-2626 Ph: (202) 244-9300 |
| NPI Number | 1023743085 |
|---|---|
| Provider Enumeration Date | 07/22/2022 |
| Last Update Date | 11/11/2022 |
| Medicare PECOS PAC ID | 5294110854 |
|---|---|
| Medicare Enrollment ID | O20220917000026 |
News Archive
Collagen Matrix, Inc., the leader in collagen- and mineral-based matrix engineering, announced today that it has received FDA's 510(k) clearance of a new Collagen Dental Membrane derived from porcine dermis indicated for use in oral surgical procedures involving guided tissue and bone regeneration.
Independent clinical trials, including one conducted at the Scheie Eye Institute at the Perelman School of Medicine, have reported safety and efficacy for Leber congenital amaurosis (LCA), a congenital form of blindness caused by mutations in a gene (RPE65) required for recycling vitamin A in the retina. Inherited retinal degenerative diseases were previously considered untreatable and incurable.
Scars are often the unwanted and permanent result of wound healing, but University of California, Irvine and University of Pennsylvania researchers have discovered a natural regeneration process that stimulates scar-free skin repair.
GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023743085 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Paul A Silver |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1619046976 PECOS PAC ID: 0648235523 Enrollment ID: I20041120000186 |
News Archive
Collagen Matrix, Inc., the leader in collagen- and mineral-based matrix engineering, announced today that it has received FDA's 510(k) clearance of a new Collagen Dental Membrane derived from porcine dermis indicated for use in oral surgical procedures involving guided tissue and bone regeneration.
Independent clinical trials, including one conducted at the Scheie Eye Institute at the Perelman School of Medicine, have reported safety and efficacy for Leber congenital amaurosis (LCA), a congenital form of blindness caused by mutations in a gene (RPE65) required for recycling vitamin A in the retina. Inherited retinal degenerative diseases were previously considered untreatable and incurable.
Scars are often the unwanted and permanent result of wound healing, but University of California, Irvine and University of Pennsylvania researchers have discovered a natural regeneration process that stimulates scar-free skin repair.
GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.
› Verified 7 days ago
| Provider Name | Amy Stone |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1013086347 PECOS PAC ID: 8224223003 Enrollment ID: I20101108000376 |
News Archive
Collagen Matrix, Inc., the leader in collagen- and mineral-based matrix engineering, announced today that it has received FDA's 510(k) clearance of a new Collagen Dental Membrane derived from porcine dermis indicated for use in oral surgical procedures involving guided tissue and bone regeneration.
Independent clinical trials, including one conducted at the Scheie Eye Institute at the Perelman School of Medicine, have reported safety and efficacy for Leber congenital amaurosis (LCA), a congenital form of blindness caused by mutations in a gene (RPE65) required for recycling vitamin A in the retina. Inherited retinal degenerative diseases were previously considered untreatable and incurable.
Scars are often the unwanted and permanent result of wound healing, but University of California, Irvine and University of Pennsylvania researchers have discovered a natural regeneration process that stimulates scar-free skin repair.
GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.
› Verified 7 days ago
| Provider Name | James Williams |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1770664534 PECOS PAC ID: 8628093994 Enrollment ID: I20110706000048 |
News Archive
Collagen Matrix, Inc., the leader in collagen- and mineral-based matrix engineering, announced today that it has received FDA's 510(k) clearance of a new Collagen Dental Membrane derived from porcine dermis indicated for use in oral surgical procedures involving guided tissue and bone regeneration.
Independent clinical trials, including one conducted at the Scheie Eye Institute at the Perelman School of Medicine, have reported safety and efficacy for Leber congenital amaurosis (LCA), a congenital form of blindness caused by mutations in a gene (RPE65) required for recycling vitamin A in the retina. Inherited retinal degenerative diseases were previously considered untreatable and incurable.
Scars are often the unwanted and permanent result of wound healing, but University of California, Irvine and University of Pennsylvania researchers have discovered a natural regeneration process that stimulates scar-free skin repair.
GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.
› Verified 7 days ago
| Provider Name | Christopher Duke |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1942225396 PECOS PAC ID: 7315112166 Enrollment ID: I20111207000208 |
News Archive
Collagen Matrix, Inc., the leader in collagen- and mineral-based matrix engineering, announced today that it has received FDA's 510(k) clearance of a new Collagen Dental Membrane derived from porcine dermis indicated for use in oral surgical procedures involving guided tissue and bone regeneration.
Independent clinical trials, including one conducted at the Scheie Eye Institute at the Perelman School of Medicine, have reported safety and efficacy for Leber congenital amaurosis (LCA), a congenital form of blindness caused by mutations in a gene (RPE65) required for recycling vitamin A in the retina. Inherited retinal degenerative diseases were previously considered untreatable and incurable.
Scars are often the unwanted and permanent result of wound healing, but University of California, Irvine and University of Pennsylvania researchers have discovered a natural regeneration process that stimulates scar-free skin repair.
GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.
› Verified 7 days ago
| Provider Name | Andrea Hulse |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1679532220 PECOS PAC ID: 5092744672 Enrollment ID: I20120601000355 |
News Archive
Collagen Matrix, Inc., the leader in collagen- and mineral-based matrix engineering, announced today that it has received FDA's 510(k) clearance of a new Collagen Dental Membrane derived from porcine dermis indicated for use in oral surgical procedures involving guided tissue and bone regeneration.
Independent clinical trials, including one conducted at the Scheie Eye Institute at the Perelman School of Medicine, have reported safety and efficacy for Leber congenital amaurosis (LCA), a congenital form of blindness caused by mutations in a gene (RPE65) required for recycling vitamin A in the retina. Inherited retinal degenerative diseases were previously considered untreatable and incurable.
Scars are often the unwanted and permanent result of wound healing, but University of California, Irvine and University of Pennsylvania researchers have discovered a natural regeneration process that stimulates scar-free skin repair.
GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.
› Verified 7 days ago
News Archive
Collagen Matrix, Inc., the leader in collagen- and mineral-based matrix engineering, announced today that it has received FDA's 510(k) clearance of a new Collagen Dental Membrane derived from porcine dermis indicated for use in oral surgical procedures involving guided tissue and bone regeneration.
Independent clinical trials, including one conducted at the Scheie Eye Institute at the Perelman School of Medicine, have reported safety and efficacy for Leber congenital amaurosis (LCA), a congenital form of blindness caused by mutations in a gene (RPE65) required for recycling vitamin A in the retina. Inherited retinal degenerative diseases were previously considered untreatable and incurable.
Scars are often the unwanted and permanent result of wound healing, but University of California, Irvine and University of Pennsylvania researchers have discovered a natural regeneration process that stimulates scar-free skin repair.
GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.
› Verified 7 days ago
Mary's Center For Maternal And Child Care, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1221 Taylor St Nw, Washington, DC 20011 Phone: 202-464-9200 | |
I Bar Wellness Center Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1263 Evarts St Ne, Washington, DC 20018 Phone: 202-957-3590 | |
Okafor Medical Associates Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7603 Georgia Avenue, Nw, Suite 100, Washington, DC 20012 Phone: 202-723-0498 Fax: 202-723-0268 | |
Dupont Circle Physicians Group Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1737 20th St Nw, Washington, DC 20009 Phone: 202-745-0201 Fax: 202-332-2794 | |
H L Yoon, Mdpc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2345 Martin Luther King Jr., Ave, S.e., Washington, DC 20020 Phone: 202-678-4940 Fax: 202-678-9703 | |
Charles Joel Bier, M.d., Pllc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1715 N St Nw, Washington, DC 20036 Phone: 202-466-4646 Fax: 202-466-4776 | |
Unity Health Care, Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1355 New York Ave Ne, Washington, DC 20002 Phone: 202-255-3469 |